Longevity Medicine, Memberships and the Evidence
Longevity care is sold through concierge memberships, standalone clinics, subscriptions and cash-only tests. How the models differ, what they cost, and what the evidence behind common services actually shows.
Updated November 2026: replaced and expanded at the editor's request; adds business models, pricing, HSA rules and a concierge vs longevity clinic comparison to the original evidence framework; evidence labels follow CMT's five evidence types.
Start here: the questions this brief answers
Longevity care comes as concierge memberships, standalone clinic memberships, subscriptions, cash-only tests and executive physicals, at very different prices. The evidence varies by service: one-time Lp(a) testing and fitness are well supported; whole-body MRI and multi-cancer blood tests are not proven to improve outcomes. The physician relationship is what turns test results into care.
How is longevity care sold?
Five models, from concierge memberships to cash-only tests. Go to the full answer ↓
What do longevity memberships cost?
Biograph lists $7,500 and $15,000 first-year tiers; contemporary concierge is mostly $100 to $750 a month (CMT estimate). Go to the full answer ↓
Can patients use an HSA?
Qualifying DPC up to $150 a month (individual) since 2026; most concierge and longevity memberships don't qualify. Go to the full answer ↓
Are full-body MRIs worth it?
The ACR says evidence is insufficient to recommend them for people without symptoms. Go to the full answer ↓
What's the difference between concierge and a longevity clinic?
A continuing relationship versus concentrated testing. Go to the full answer ↓
Part 1 · Why this brief
Longevity is now a business model. Patients need a way to judge it.
Longevity medicine sells the promise of more healthy years. It is sold through concierge memberships, standalone longevity clinics, subscriptions and cash-only tests. The evidence behind each service varies widely.
Version 1.0 of this brief introduced an evidence framework for longevity tests and treatments. Version 2.0 keeps that framework and adds the business side: how longevity care is packaged and priced, how it compares with concierge medicine, and what physicians should ask before adding a longevity service.
Longevity care is not the problem. Selling uncertain tests as certainty is. A membership earns trust when it tells patients what each service can and cannot do, and when the physician relationship, not the scanner, is the product.
Part 2 · The business models
Five ways longevity care is sold
| Model | How patients pay | What it usually includes | Example price in the public record | Evidence type |
|---|---|---|---|---|
| Concierge membership with a longevity focus | Recurring fee, often plus insurance billing | Ongoing physician relationship, access, prevention planning | Contemporary concierge is mostly about $100 to $750 a month (CMT field estimate)1 | Industry Research |
| Standalone longevity clinic membership | Annual fee, self-pay | Intensive testing day (imaging, labs, fitness), coaching | Biograph: $7,500 (Core) or $15,000 (Black), first year2; Fountain Life: about $6,500 to $21,500 a year, as described by the company3 | Industry Research |
| Cash-only, à la carte tests | Per test, self-pay | Single scans or blood panels without a continuing relationship | Varies widely; prices change often | Industry Research |
| Subscription telehealth programs | Monthly subscription | Remote visits, labs, sometimes prescriptions | Varies; CMT has no verified benchmark | Industry Research |
| Hospital executive health | Per visit, patient or employer | One- or two-day evaluation | See Brief No. 07 | Industry Research |
Direct primary care · a different model · HSA rules
Since January 1, 2026, qualifying direct primary care arrangements no longer disqualify a patient from HSA contributions, and HSA funds can pay the fee, if the arrangement provides only primary care for a fixed periodic fee of no more than $150 a month for an individual or $300 for a family in 2026.4 Concierge and longevity memberships that bill insurance, exceed the cap or include specialty services generally fall outside this rule. Patients should check with a tax professional.
These rules describe DPC, not concierge medicine, and are shown separately for context only. Not tax advice.
Example annual price points for longevity and concierge offerings
Industry ResearchSources: Biograph pricing page2; CMT field estimate for concierge tiers, method not published.1 Concierge figures are annualized ranges, not a specific practice. Prices change; confirm before publishing.
Part 3 · The evidence framework
What the evidence says about common longevity services
Each row shows the evidence type behind the finding and a separate verdict marked as CMT's editorial reading. Evidence types describe the kind of evidence, not its value. The CMT reading is a plain-language summary for clinicians, not a clinical recommendation for any patient.
| Service | Evidence type | What the evidence says | CMT editorial reading |
|---|---|---|---|
| Whole-body MRI screening (no symptoms) | Practice Insight | The ACR found insufficient evidence to recommend total-body screening and no documented evidence it is cost-efficient or prolongs life.5 Radiology leaders warn of false positives and overdiagnosis as use grows.6 | Not a screening substitute. If offered, disclose uncertainty and the likelihood of incidental findings. |
| Multi-cancer blood test (Galleri) | Clinical Trial Evidence | In the randomized NHS-Galleri trial of about 142,000 people, the primary endpoint of reducing stage III to IV cancers was not met, though stage IV diagnoses fell.7 An FDA panel backed the test in 2026, but that is not approval; the panel urged continuing standard screening.8 | Promising but unproven for outcomes. Never replaces guideline screening. |
| Lipoprotein(a), measured once | Practice Insight | The National Lipid Association recommends measuring Lp(a) at least once in every adult; European and Canadian guidance agree.9 | Reasonable and inexpensive; acting on a high result means managing other risk factors more intensively. |
| Coronary artery calcium (CAC) score | Policy and Law | The USPSTF found insufficient evidence to add CAC to routine risk assessment.10 Cardiology guidelines support CAC for intermediate-risk adults when it would change statin decisions.11 | Useful when the result would change treatment; not a universal screen. |
| Cardiorespiratory fitness (VO2 max or treadmill) | Population Data | Among 122,007 patients, the lowest-fitness group had about five times the adjusted mortality of the most fit, a risk comparable to or greater than smoking or diabetes.12 Observational: fitness may also reflect other healthy traits. | Strong signal and modifiable. Exercise prescription may matter more than the test. |
For every longevity service, ask: if the result is abnormal, what will we do differently, and is there evidence that doing it helps? If there is no answer, the test produces information, not care.
Part 4 · Concierge vs longevity clinic
Relationship or testing day?
Concierge strength
A continuing relationship with a physician who knows the patient and can act on results over years. Studies of one large network link membership with fewer hospitalizations, though they are observational and network-affiliated.13 A 2025 systematic review examined cost, access and outcomes.14
Longevity clinic strength
Concentrated, convenient testing and coaching. Pricing is clear and published.2
Shared risk
Selling tests with uncertain benefit as certainty. Incidental findings can lead to anxiety, further tests and costs that the membership may not cover.5
Before adding a longevity service to your membership
0 complete
Nothing you check is saved or sent anywhere. Educational self-review only.
Learn → Build → Lead
Putting it to work
Longevity services range from well supported to unproven; label them honestly.
Run the checklist before adding any test to a membership.
Make the physician relationship, not the scanner, the core of what you sell.
Methods, limitations and evidence types
How this brief was built
CMT rebuilt this brief at the editor's request, replacing Version 1.0. Each scorecard row shows the evidence type and, separately, a verdict marked as CMT's editorial reading. Company prices come from company pages and trade reports and are labeled Industry Research. DPC appears only in the dashed HSA box.
Every key finding is labeled by evidence type. Labels describe the type of evidence, not its value. Each type answers different questions. Funding is disclosed on every source.
What we don't know
- No independent study compares outcomes of longevity clinic members with concierge members.
- Longevity clinic prices change frequently and some are quote-based.
- Final FDA action on multi-cancer blood tests was pending at publication.
- CMT has no verified benchmark for subscription telehealth longevity programs.
How to cite this brief
Concierge Medicine Today. Longevity Medicine, Memberships and the Evidence. CMT Research Brief No. 31, Version 2.0. November 2026. conciergemedicinetoday.net/longevity-evidence-grades.
External review: This brief has not been externally peer reviewed. Corrections: CMT corrects factual errors promptly and notes the change in the updates line. Send corrections through conciergemedicinetoday.net/contact.
Keep reading
Related CMT Research Briefs
References
Sources and citations
- Concierge Medicine Today. Concierge price tier field estimates. CMT field estimate, method not published. conciergemedicinetoday.netEvidence type: Industry Research · Funding: Concierge Medicine Today (self-conducted; no outside funder)
- Biograph. Memberships page: Core $7,500 and Black $15,000, first year. Accessed November 2026. biograph.comEvidence type: Industry Research · Funding: not stated (company pricing page)
- AgeMed. Report on longevity clinic pricing; Fountain Life memberships from $6,500 to $21,500 a year as described by the company. agemed.orgEvidence type: Industry Research · Funding: not stated (trade article quoting company)
- Internal Revenue Service. Notice 2026-5, Expanded availability of health savings accounts under the One, Big, Beautiful Bill Act. December 2025. Fee limits as summarized by HUB International and Groom Law Group. irs.govEvidence type: Policy and Law · Funding: federal (IRS)
- American College of Radiology. ACR statement on screening total body MRI. April 17, 2023. Reaffirmed per ACR spokesperson, October 2024 (Radiology Today). acr.orgEvidence type: Practice Insight · Funding: not stated (professional society statement)
- RSNA News. Whole-body MRI expands, leaving patients weighing risks. July 2026. rsna.orgEvidence type: Practice Insight · Funding: not stated (society news report)
- Patient Care. NHS-Galleri data show fewer stage IV cancers, but primary endpoint missed. February 20, 2026. Randomized trial of about 142,000 participants. Summary via Patient Care, citing GRAIL. patientcareonline.comEvidence type: Clinical Trial Evidence · Funding: industry (GRAIL; trial run with NHS England), per company and trade reports
- Patient Worthy. Galleri moves closer to FDA decision as evidence on multi-cancer blood testing evolves. October 4, 2026. Summary via Becker's Hospital Review of the FDA advisory panel's nonbinding recommendation. patientworthy.comEvidence type: Policy and Law · Funding: not stated (news report)
- Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of Clinical Lipidology. 2024. doi:10.1016/j.jacl.2024.03.001. pubmed.ncbi.nlm.nih.govEvidence type: Practice Insight · Funding: not stated (professional society statement; check article disclosures)
- U.S. Preventive Services Task Force. Risk assessment for cardiovascular disease with nontraditional risk factors (ABI, hsCRP, CAC). 2018 recommendation (I statement). Summary via The Hospitalist. the-hospitalist.orgEvidence type: Policy and Law · Funding: federal (AHRQ supports the USPSTF)
- 2018 AHA/ACC multisociety guideline on the management of blood cholesterol. CAC recommendation for intermediate-risk adults. Summary via AAFP, October 2, 2023. aafp.orgEvidence type: Practice Insight · Funding: not stated (guideline; check disclosures)
- Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Network Open. 2018;1(6):e183605. 122,007 patients. healio.comEvidence type: Population Data · Funding: not stated; authors reported no relevant financial disclosures (per Healio)
- Klemes A, et al. Personalized preventive care leads to significant reductions in hospital utilization. American Journal of Managed Care. 2012;18(12):e453-e460. ajmc.comEvidence type: Population Data · Funding: not confirmed by CMT; authors included MDVIP medical leadership
- Rylands KS, Collins CM, Collins DR. Maximizing the value of concierge medicine: a systematic review of cost, access, and outcomes. American Journal of Medicine. 2025;138(9):1201-1213. doi.orgEvidence type: Clinical Trial Evidence · Funding: not stated (check article)
Disclaimer
This brief is educational and informational only. It is not medical, legal, tax, financial or accounting advice, and it is not media training or a substitute for advice from a qualified professional. Concierge Medicine Today is an independent trade publication: no organization paid for favorable coverage, no practice model is favored, and funding is disclosed for every source cited. Product, company and organization names are used for identification and context only and do not imply endorsement. While we work to be accurate, this content is not without possible error or omission. © 2007-2026 Concierge Medicine Today, LLC. All rights reserved.
Concierge Medicine Today · independent trade publication since 2007 · Learn → Build → Lead

